raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:320365

Autosomal dominant spastic paraplegia type 36

Synonyms: SPG36

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant
Age of onset
Adolescent, Adult
Status
active

A complex form of hereditary spastic paraplegia, characterized by an onset in childhood or adulthood of progressive spastic paraplegia (with spastic gait, spasticity, lower limb weakness, pes cavus and urinary urgency) associated with the additional manifestation of peripheral sensorimotor neuropathy.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enAutosomal dominant spastic paraplegia type 36SPG36
frParaplégie spastique autosomique dominante type 36= en
deSpastische Paraplegie, autosomal-dominante, Typ 36= en
esParaplejía espástica autosómica dominante tipo 36= en
itParaplegia spastica autosomica dominante, tipo 36= en
nlAutosomaal dominante spastische paraplegie type 36= en
ptParaplegia espástica autossómica dominante tipo 36
plAutosomalna dominująca paraplegia spastyczna typu 36= en
csAutozomálně dominantní spastická paraplegie, typ 36= en
ukАутосомно-домінантна спастична параплегія, тип 36= en
zh常染色体显性遗传痉挛性截瘫36型= en
trOtozomal dominant spastik parapleji tip 36= en

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM613096Evalidated
ICD-10G11.4NTBTattributedvalidated
ICD-118B44.00NTBTattributedvalidated
MONDO0013132Evalidated
MeSHC567930Evalidated
UMLSC2936879Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
SPG36Disease-causing germline mutation(s) inAssessedHGNC:3324012q23-q24spastic paraplegia 36 (autosomal dominant)19357379[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families1 familiesWorldwideFamily(ies)Validated19357379[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET_19357379[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

20 annotations · validated 2018-04-18
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0003487Babinski sign
HP:0001347Hyperreflexia
HP:0002061Lower limb spasticity
HP:0007020Progressive spastic paraplegia
HP:0002064Spastic gait
Frequent (79-30%)
HP:0007220Demyelinating motor neuropathy
HP:0011402Demyelinating sensory neuropathy
HP:0002460Distal muscle weakness
HP:0006858Impaired distal proprioception
HP:0006937Impaired distal tactile sensation
HP:0006886Impaired distal vibration sensation
HP:0010829Impaired temperature sensition
HP:0003701Proximal muscle weakness
HP:0000020Urinary incontinence
HP:0000012Urinary urgency
Occasional (29-5%)
HP:0001369Arthritis
HP:0001761Pes cavus
HP:0000486Strabismus
Excluded (0%)
HP:0012747Abnormal brainstem MRI signal intensity
HP:0000726Dementia

Run the differential on the 5 obligate / very frequent terms

Annotation source: 19357379[PMID]

7

Sources for this card